COVID-19 Long-Acting Antibodies Discovered by Vanderbilt University Medical Center Move to Phase 3 C

AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University ... Read more

Bron:

Newswise: MedNews